Lv6
1880 积分 2021-07-29 加入
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody–Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors
2天前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
4天前
已完结
Bottom–Up Protein Analysis Workflow for Simultaneous Characterization of Payloads, Disulfide Bonds, and Free Thiols in Antibody–Drug Conjugates
6天前
已完结
Multispecific T-cell engagers attract cancer drug developers
6天前
已完结
Discovery and Characterization of a New Class of C5aR1 Antagonists Showing In Vivo Activity
10天前
已完结
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
16天前
已完结
Measuring PI3K Lipid Kinase Activity
16天前
已完结
Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease
17天前
已完结
Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer
17天前
已完结
Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer
18天前
已完结
皖公网安备34019202002308
